Novavax, Inc.

Halal Rating :
See Details
Last Price $5.38 Last updated:
Market Cap $523.86m
7D Change 1.7%
1 Year Change -22.37%

Company Overview

  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing
Exchange NASDAQ
Next Earnings Date Feb. 27, 2024

Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company is headquartered in Gaithersburg, Maryland.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Dec. 31, 2023 $291.34m $581.32m - $4.12m 0.00% 0.71%
Sept. 30, 2023 $186.99m $315.48m - $2.86m 0.00% 0.91%
June 30, 2023 $424.43m $381.59m - $3.12m 0.00% 0.82%

Company Impact

Help us evaluate Novavax, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates